HIV-1 Subtype Susceptibility to Entry Inhibitors in China
Author Information
Author(s): Yu Xiaoling, Yuan Lin, Huang Yang, Xu Weisi, Fang Zhiming, Liu Shuwen, Shao Yiming, Jiang Shibo, Ma Liying
Primary Institution: State Key Laboratory for Infection Disease Prevention and Control, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China-CDC), Beijing, China
Hypothesis
What is the baseline susceptibility of predominant HIV-1 subtypes in China to HIV entry inhibitors?
Conclusion
There are significant differences in baseline susceptibility to HIV entry inhibitors among the predominant HIV-1 subtypes in China.
Supporting Evidence
- CRF07_BC isolates were about 5-fold less sensitive to enfuvirtide than B′ and CRF01_AE isolates.
- Subtype B′ isolates were about 4- to 5-fold more sensitive than CRF07_BC and CRF01_AE isolates to maraviroc and TAK779.
- AMD3100 showed no significant inhibitory activity against any of the isolates tested.
Takeaway
This study looked at how different types of HIV in China respond to new medicines that stop the virus from entering cells. It found that some types are more resistant than others.
Methodology
The study tested the susceptibility of 14 HIV-1 isolates to various entry inhibitors using virus inhibition assays.
Potential Biases
Potential biases may arise from the limited diversity of the sample and the specific geographic focus.
Limitations
The study had a relatively small sample size and high variation in susceptibility data.
Participant Demographics
The participants included 11 males and 3 females, averaging 37.6 years old, infected through various pathways.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website